Positive New Data from Phase 1/2 Trial of AT-01 (Iodine : co

AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific...

Related Keywords

Canada , Vancouver , British Columbia , San Francisco , California , United States , Emily Martin , Luke Heagle , Attralus Inc , University Of Tennessee Research Foundation , Society Of Nuclear Medicine Molecular Imaging , University Of Tennessee Graduate School Medicine , Cancer Theranostics Program , Tennessee Graduate School , Nuclear Medicine , Molecular Imaging , Annual Meeting , Imaging Results , Oral Presentation , Final Results , First In Human Study , Amyloid Reactive Peptide , Iodine Evuzamitide , Systemic Amyloidosis , Jonathan Wall , Distinguished Professor , Integrated Session , Cardiac Amyloidosis , Systemic Amyloidosis Using , Identifies Organ Specific , Amyloid Regression , Associate Professor , Meet The Author Poster Hall Reception , Tennessee Research , Attralus , Nc , Snmmi , Amyloidosis , Iagnostic ,